Member Directory

SKYDD Biotechnology Pty Ltd

Website: http://www.skyddbiotech.com.au/

Member Contact: Nigel Blair

Position: Executive Director

Industry: Biotech & Pharmaceuticals

Company Profile:

SKYDD Biotechnology Pty Ltd owns the IP globally for a preventative product made from natural occurring ingredients, that may have broad application for the prevention of infectious diseases.

Primarily focused on the prevention of COVID 19 initially (but study tests are being also further incorporated for Influenza A&B and RSV).

SKYDD has been approved by St Vincents Ethics Committee to undertake a Clinical trial for a randomised, double-blind, placebo-controlled, single-centre investigation of the safety, tolerability and pharmacokinetics of 0.03% SSTK-101 nasal and oral spray as single or multiple administrations in healthy volunteers.

The clinical trial shall be undertaken with the Doherty Clinical Trials part of the Doherty Institute and along with other leading institutions.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.